Angel K. Markov

530 total citations
30 papers, 455 citations indexed

About

Angel K. Markov is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Angel K. Markov has authored 30 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Pathology and Forensic Medicine and 7 papers in Physiology. Recurrent topics in Angel K. Markov's work include Diet, Metabolism, and Disease (9 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Angel K. Markov is often cited by papers focused on Diet, Metabolism, and Disease (9 papers), Eicosanoids and Hypertension Pharmacology (6 papers) and Nitric Oxide and Endothelin Effects (5 papers). Angel K. Markov collaborates with scholars based in United States and Venezuela. Angel K. Markov's co-authors include Harper K. Hellems, Patrick H. Lehan, Ralph Didlake, William A. Neely, Jack R. Lewin, John D. Bower, Kent A. Kirchner, Hari Cohly, Edward E. Smith and Michael H. LeBlanc and has published in prestigious journals such as Circulation, Gastroenterology and Critical Care Medicine.

In The Last Decade

Angel K. Markov

29 papers receiving 442 citations

Peers

Countries citing papers authored by Angel K. Markov

Since Specialization

Citations

This map shows the geographic impact of Angel K. Markov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angel K. Markov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angel K. Markov more than expected).

Fields of papers citing papers by Angel K. Markov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angel K. Markov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angel K. Markov. The network helps show where Angel K. Markov may publish in the future.

Co-authorship network of co-authors of Angel K. Markov

This figure shows the co-authorship network connecting the top 25 collaborators of Angel K. Markov. A scholar is included among the top collaborators of Angel K. Markov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angel K. Markov. Angel K. Markov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Observations on the Use of the aVR−V6 Relationship to Recognize Limb Lead Error 2008 ·Journal of Emergency Medicine ·(unknown), (unknown), Angel K. Markov	1
2	Influence of Fructose-1,6-Diphosphate on Endotoxin-Induced Lung Injuries in Sheep 2006 ·Journal of Surgical Research ·Angel K. Markov, (unknown), Hari Cohly, (unknown), Thomas N. Skelton	7
3	Einthoven's Triangle: Lead Errors and an Algorithm for Solution 2005 ·The American Journal of the Medical Sciences ·(unknown), (unknown), Angel K. Markov	14
4	Fructose‐1,6‐Diphosphate Suppresses T‐Lymphocyte Proliferation, Promotes Apoptosis and Inhibits Interleukins‐1, 6, β‐Actin mRNAs, and Transcription Factors Expression 2004 ·Immunological Investigations ·Hari Cohly, (unknown), Thomas N. Skelton, Edward F. Meydrech, Angel K. Markov	13
5	Fructose-1,6-diphosphate alone and in combination with cyclosporine potentiates rat cardiac allograft survival and inhibits lymphocyte proliferation and interleukin-2 expression1 2002 ·Transplantation ·Angel K. Markov, (unknown), (unknown), (unknown), Charles K. Moore, Bobby Heath, Hari Cohly	11
6	PREVENTION OF α-NAPHTHYLTHIOUREA-INDUCED PULMONARY EDEMA WITH FRUCTOSE-1,6-DIPHOSPHATE 2002 ·Experimental Lung Research ·Angel K. Markov, (unknown), Ralph Didlake, Luciano B. Lemos	7
7	Effect of fructose-1, 6-diphosphate versus diphenhydramine on mortality in compound 48/80-induced shock 2001 ·Toxicology Letters ·(unknown), (unknown), Hari Cohly, Patrick H. Lehan, Angel K. Markov	5
8	Metabolic responses to fructose-1,6-diphosphate in healthy subjects 2000 ·Metabolism ·Angel K. Markov, William A. Neely, Ralph Didlake, (unknown), (unknown), Patrick H. Lehan	17
9	The role of fructose-1, 6-diphosphate in cell migration and proliferation in an in vitro xenograft blood vessel model of vascular wound healing 1999 ·In Vitro Cellular & Developmental Biology - Animal ·Hari Cohly, James W. Stephens, Michael Angel, James C. Johnson, Angel K. Markov	3
10	In vitro induction of nitric oxide by fructose-1,6-diphosphate in the cardiovascular system of rats 1998 ·Molecular and Cellular Biochemistry ·(unknown), (unknown), Angel K. Markov	6
11	Effects of Fructose-1,6-Diphosphate on the Activity of Rat Liver Nitric Oxide Synthase in vitro 1997 ·Pharmacology ·Anastasios A. Mihas, (unknown), (unknown), (unknown), Angel K. Markov	10
12	Plasma Oxidase Assay for Screening of Myocardial Infarction 1994 ·The American Journal of the Medical Sciences ·Gabriel P. Lasala, (unknown), (unknown), Samer Y. Siouffi, Thomas N. Skelton, Patrick H. Lehan, Angel K. Markov	2
13	Fructose-1,6-Diphosphate, when Given Five Minutes after Injury, Does Not Ameliorate Hypoxic Ischemic Injury to the Central Nervous System in the Newborn Pig 1991 ·Neonatology ·Michael H. LeBlanc, (unknown), Angel K. Markov, Owen B. Evans, (unknown), Edward E. Smith, Edwin G. Brown	16
14	Protective Effects of Misoprostol on Carbon Tetrachloride-Induced Liver Damage in the Rat 1991 ·Pharmacology ·Anastasios A. Mihas, Angel K. Markov, (unknown)	7
15	Fructose-1,6-bisphosphate, when given immediately before reoxygenation, or before injury, does not ameliorate hypoxic ischemic injury to the central nervous system in the newborn pig 1991 ·Critical Care Medicine ·Michael H. LeBlanc, (unknown), Owen B. Evans, (unknown), Edward E. Smith, Angel K. Markov	20
16	Fructose 1–6 diphosphate prevents intestinal ischemic reperfusion injury and death in rats 1990 ·Gastroenterology ·(unknown), (unknown), Angel K. Markov	47
17	Cerebral resuscitation with succinate and fructose-1, 6-diphosphate 1989 ·PubMed ·(unknown), John P. Kapp, Frederick Munschauer, Angel K. Markov, David W. Shucard	6
18	Attenuation of ischemic renal injury with fructose 1,6-diphosphate 1989 ·Journal of Surgical Research ·Ralph Didlake, Kent A. Kirchner, Jack R. Lewin, John D. Bower, Angel K. Markov	37
19	Hemodynamics and metabolic effects of fructose 1–6 diphosphate in ischemia and shock — experimental and clinical observations 1986 ·Annals of Emergency Medicine ·Angel K. Markov	60
20	External measurement and mapping of myocardial isotope after coronary venous 85krypton and 133xenon injections 1974 ·The American Journal of Cardiology ·(unknown), Angel K. Markov, Patrick H. Lehan, (unknown), (unknown), (unknown), Harper K. Hellems	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact